Dr. Catherine P. Benziger, MD

Dr. Benziger practices at Essentia Health-St. Mary's Medical Center in Duluth, Minnesota, part of Essentia Health.

Dr. Benziger's NPI, 1518266394, was assigned on March 20, 2011. Dr. Benziger graduated from University Of Minnesota Medical School in 2011. Dr. Benziger's Washington license number on file is MD60391079.

Dr. Benziger's primary practice is Essentia Health-St. Mary's Medical Center, at 402 East Second Street, Duluth, MN 55805 in St. Louis County. The practice phone is (218) 786-3574. Dr. Benziger also practices at Essentia Health St Marys Medical Center, 407 E 3rd St, Duluth, MN 55805.

Dr. Benziger's primary practice is Essentia Health-St. Mary's Medical Center in Duluth, Minnesota, part of Essentia Health. Dr. Benziger is also affiliated with Essentia Health-Duluth (Miller-Dwan, Building D). The medical group on file is Essentia Health-Duluth Clinic. Dmand AI also links Dr. Benziger to 3 more hospitals, 3 group practices and clinics, 3 medical groups and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benziger practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Benziger's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Benziger is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Benziger's licenses on file in 3 states: Washington, Minnesota and Wisconsin.

Dmand AI lists atrial fibrillation and flutter, cerebrovascular disease, chronic hypertension, chronic skin ulcer, coronary artery disease, heart attack, heart blockage and heart failure among the conditions Dr. Benziger treats.

CMS data shows 1,343 Medicare services from Dr. Benziger across 16 procedure codes in 2024, for 947 Medicare patients. Medicare paid $29,705 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 947 Medicare patients who saw Dr. Benziger in 2024. The largest group is 65 to 74, with 358 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Benziger's median patient age at 70, with 50% women.

In 2024, Dr. Benziger wrote 2,670 Medicare Part D claims for 424 patients. 72% of them were for generic drugs. CMS names the drug for 2,532 of them, across 33 drugs with 11 or more claims each, at $772,338 in total drug cost. In 2023, CMS named 1,993 claims across 31 drugs.

Dr. Benziger accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 41 papers to Dr. Benziger, published from 2012 to 2024. 2023 was the busiest year, with 8. The most frequent topics are Cardiovascular Diseases, Aspirin and Myocardial Infarction. Dr. Benziger has published most often in Glob Heart. Dr. Benziger's most frequent co-authors are Mark Bernard Effron, MD, Kamal Gupta, MD and Tamar S. Polonsky.

Dmand AI links Dr. Benziger to 11 clinical trials, 5 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Hyperlipoproteinemia Type II, Atherosclerosis and Cognitive Dysfunction. Amgen sponsors the most, 2.

CMS Open Payments shows 30 general payments to Dr. Benziger from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 81% of the total. Novartis Pharmaceuticals Corporation paid the most, $10,982.

Dmand AI lists 16 awards for Dr. Benziger, most recently Bruce-Laughlin Award in 2015.

Dr. Benziger graduated from University Of Minnesota Medical School in 2011. Dr. Benziger is a member of ACC and AHA.

Dr. Benziger is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.